{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:58:00Z","timestamp":1775192280095,"version":"3.50.1"},"reference-count":35,"publisher":"SLACK, Inc.","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To describe a process for identifying birth weight (BW) and gestational age (GA) screening guidelines in Mongolia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>This was a prospective cohort study in a tertiary care hospital in Ulaanbataar, Mongolia, of 193 premature infants with GA of 36 weeks or younger and\/or BW of 2,000 g or less) with regression analysis to determine associations between BW and GA and the development of retinopathy of prematurity (ROP).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n              As BW and GA decreased, the relative risk of developing ROP increased. The relative risk of developing any stage of ROP in infants born at 29 weeks or younger was 2.91 (95% CI: 1.55 to 5.44;\n              <jats:italic>P<\/jats:italic>\n              &lt; .001] compared to older infants. The relative risk of developing any type of ROP in infants with BW of less than 1,200 g was 2.41 (95% CI: 1.35 to 4.29;\n              <jats:italic>P<\/jats:italic>\n              = .003] and developing type 2 or worse ROP was 2.05 (95% CI: 0.99 to 4.25;\n              <jats:italic>P<\/jats:italic>\n              = .05).\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Infants in Mongolia with heavier BW and older GA who fall outside of current United States screening guidelines of GA of 30 weeks or younger and\/or BW of 1,500 g or less developed clinically relevant ROP.<\/jats:p>\n            <jats:p>\n              <jats:bold>\n                [\n                <jats:italic>J Pediatr Ophthalmol Strabismus<\/jats:italic>\n                . 2020;57(5):333\u2013339.]\n              <\/jats:bold>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.3928\/01913913-20200804-01","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:16:34Z","timestamp":1600704994000},"page":"333-339","source":"Crossref","is-referenced-by-count":8,"title":["Development of Screening Criteria for Retinopathy of Prematurity in Ulaanbaatar, Mongolia, Using a Web-based Data Management System"],"prefix":"10.3928","volume":"57","author":[{"given":"Shelbi L.","family":"Olson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsengelmaa","family":"Chuluunbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily D.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn E.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munkhuu","family":"Bayalag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chimgee","family":"Chuluunkhuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nita G.","family":"Valikodath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. Hunter","family":"Cherwek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Congdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie D.","family":"MacKeen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Hallak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivien","family":"Yap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Ostmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Peter","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael F.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. V. Paul","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.3.311"},{"key":"e_1_3_1_3_2","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Good WV","year":"2004","unstructured":"Good WVEarly Treatment for Retinopathy of Prematurity Cooperative Group. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. Trans Am Ophthalmol Soc. 2004;102:233\u2013248.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-2996"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.84"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2007.11.009"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.04.018"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)01107-0"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1180"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-0978"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.3928\/01913913-20091118-08"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1076\/opep.9.4.271.1512"},{"key":"e_1_3_1_13_2","volume-title":"Health systems in transition: Mongolia-health systems review","author":"Tsilaajav T","year":"2013","unstructured":"Tsilaajav T, Ser-Od E, Baasai B, Byambaa G, Shagdarsuren O. Health systems in transition: Mongolia-health systems review. Geneva: World Health Organization; 2013."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60820-4"},{"key":"e_1_3_1_15_2","unstructured":"Rashtriya Bal Swathya KaryakramMinistry of Health & Family Welfare Government of India. Guidelines for Universal Eye Screening in Newborns Including Retinopathy of Prematurity. 2017. Accessed at: https:\/\/nhm.gov.in\/images\/pdf\/programmes\/RBSK\/Resource_Documents\/Revised_ROP_Guidelines-Web_Optimized.pdf"},{"key":"e_1_3_1_16_2","unstructured":"\u201cRetinopathy of Prematurity.\u201d National Neonatology Forum of India Policy Guidelines . Accessed at: https:\/\/www.ontop-in.org\/ontop-pen\/Week-12-13\/ROP%20NNF%20Guidelines%20.pdf"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.123.7.991"},{"issue":"3","key":"e_1_3_1_18_2","first-page":"223","article-title":"Screening for retinopathy of prematurity (ROP) in the middle Black Sea region of Turkey","volume":"54","author":"Beden U","year":"2012","unstructured":"Beden U, Demir S, Ayg\u00fcn C, K\u00fc\u00e7\u00fck\u00f6d\u00fck S, Erkan D. Screening for retinopathy of prematurity (ROP) in the middle Black Sea region of Turkey. Turk J Pediatr. 2012;54(3):223\u2013229.","journal-title":"Turk J Pediatr"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23158"},{"issue":"2","key":"e_1_3_1_20_2","first-page":"72","article-title":"Proposed new retinopathy of prematurity screening criteria: evidence for including older and heavier Filipino premature babies","volume":"38","author":"Corpus K","year":"2013","unstructured":"Corpus K, Jimenez JM, Anzures R, Bascuna RI, Ventura R, Reandelar MRetinopathy of Prematurity Working Group. Proposed new retinopathy of prematurity screening criteria: evidence for including older and heavier Filipino premature babies. Philipp J Ophthalmol. 2013;38(2):72\u201379.","journal-title":"Philipp J Ophthalmol"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2012.03.002"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306286"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-014-2716-1"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2014.253"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.33817"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70006-8"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S80487"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161692"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181c9696a"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2011.06.011"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.04.035"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.125.7.875"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1258\/jtt.2008.003001"},{"issue":"9","key":"e_1_3_1_34_2","first-page":"2749","article-title":"Evaluation of birth weight and gestational age in infants with treatment requiring retinopathy of prematurity in ROPE-SOS trial","volume":"59","author":"Valikodath N","year":"2018","unstructured":"Valikodath N, Shah P, Chan RV, et al. Evaluation of birth weight and gestational age in infants with treatment requiring retinopathy of prematurity in ROPE-SOS trial. Invest Ophthalmol Vis Sci. 2018;59(9):2749.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"e_1_3_1_35_2","first-page":"6522","article-title":"Retinopathy of prematurity screening criteria based on the ROPE-SOS trial in India","volume":"60","author":"Valikodath N","year":"2019","unstructured":"Valikodath N, Chan RV, Beca F, et al. Retinopathy of prematurity screening criteria based on the ROPE-SOS trial in India. Invest Ophthalmol Vis Sci. 2019;60(9):6522.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"e_1_3_1_36_2","first-page":"5307","article-title":"iTeleGEN: development of a web-based diabetic retinopathy education module","volume":"60","author":"Cole E","year":"2019","unstructured":"Cole E, Beca F, Gil GL, et al. iTeleGEN: development of a web-based diabetic retinopathy education module. Invest Ophthalmol Vis Sci. 2019;60(9):5307.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/01913913-20200804-01","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T22:29:18Z","timestamp":1683066558000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/01913913-20200804-01"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.3928\/01913913-20200804-01"],"URL":"https:\/\/doi.org\/10.3928\/01913913-20200804-01","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}